Neonatal Hemolytic Disease Caused by Anti-e and Anti-C Antibodies Treated with Intensive Phototherapy: A Case Report
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
ABO and Rh incompatibility are the leading causes of hemolytic disease of the fetus and newborn (HFDN). Due to the high antigenicity of the D antigen, hemolysis and symptoms progress rapidly. However, minor blood group incompatibility manifests varying clinical symptoms, from asymptomatic cases to neonatal jaundice and fetal hydrops. This study presents a case of HFDN in which anti-C and anti-e antibodies were identified and treated with intensive phototherapy. A full-term infant weighing 3,100 g at birth, with no complications during delivery, presented with jaundice and was admitted for intensive phototherapy. Antibody testing detected anti-C and anti-e antibodies in the neonate and the mother. The patient responded well to phototherapy, and intravenous immunoglobulin was administered. The total bilirubin levels decreased, and the infant was discharged after 5 days. At the age of 12 months, the infant exhibited normal neurodevelopment. In conclusion, neonates with HFDN, due to rare minor blood incompatibility, specifically anti-C and anti-e antibodies, can mitigate hyperbilirubinemia using phototherapy. Future research should also consider the severity of the minor blood group incompatibility.
Abstract
ABO and Rh incompatibility are the leading causes of hemolytic disease of the fetus and newborn (HFDN). Due to the high antigenicity of the D antigen, hemolysis and symptoms progress rapidly. However, minor blood group incompatibility manifests varying clinical symptoms, from asymptomatic cases to neonatal jaundice and fetal hydrops. This study presents a case of HFDN in which anti-C and anti-e antibodies were identified and treated with intensive phototherapy. A full-term infant weighing 3,100 g at birth, with no complications during delivery, presented with jaundice and was admitted for intensive phototherapy. Antibody testing detected anti-C and anti-e antibodies in the neonate and the mother. The patient responded well to phototherapy, and intravenous immunoglobulin was administered. The total bilirubin levels decreased, and the infant was discharged after 5 days. At the age of 12 months, the infant exhibited normal neurodevelopment. In conclusion, neonates with HFDN, due to rare minor blood incompatibility, specifically anti-C and anti-e antibodies, can mitigate hyperbilirubinemia using phototherapy. Future research should also consider the severity of the minor blood group incompatibility.
참고문헌 (16)
- Geaghan SM, "Diagnostic laboratory technologies for the fetus and neonate with isoimmunization", Semin Perinatol, 35, pp.148~154 (2011)
- Ross ME, "Neonatal hematology: pathogenesis, diagnosis, and management of hematologic problems", pp.65~90 (2013), Cambridge University Press
- Ozcan M, "Hyperbilirubinemia due to minor blood group(anti-E)incompatibility in a newborn : a case report", Turk Pediatri Ars, 52, pp.162~164 (2017)
- Kim HJ, "Clinical significances and distribution of unexpected antibodies found in infants", Transfus Apher Sci, pp.103765~ (2023)
- 이현지, "소아의 비예기항체 동정검사 분포와 특성: 7년간 단일기관분석", 대한수혈학회지, 26(3), pp.249~256 (2015), 대한수혈학회[DOI]
- "Blood groups and red cell antigens" (2005)[URL]
- Eder AF, "Update on HDFN : new information on long-standing controversies", Immunohematology, 22, pp.188~195 (2006)
- Agrawal A, "Minor blood group incompatibility due to blood groups other than Rh(D)leading to hemolytic disease of fetus and newborn : a need for routine antibody screening during pregnancy", Intractable Rare Dis Res, 9, pp.43~47 (2020)
- Kemper AR, "Clinical practice guideline revision : management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation", Pediatrics, 150, pp.e2022058859~ (2022)
- Sharma D, "Combined anti e and anti C Rh isoimmunisation and severe hyperbilirubinemia", Indian J Pediatr, 82, pp.570~ (2015)
- Sharma D, "Neonatal hyperbilirubinemia secondary to combined anti e and anti C isoimmunisation : a literature review", J Matern Fetal Neonatal Med, 32, pp.2009~2011 (2019)
- Yoon KJ, "A case of neonatal hemolytic disease caused by anti-C+e compound antibody", Proc of the Korean Soc Clin Lab Hematol, 2, pp.26~ (2007)
- Wagner T, "Severe HDN due to anti-Ce that required exchange tranfusion", Transfusion, 40, pp.571~574 (2000)
- 양유진, "국내 임산부의 비예기항체 빈도와 신생아의 예후 분석", 대한수혈학회지, 30(1), pp.23~32 (2019), 대한수혈학회[DOI]
- Chung HR, "The clinical significance of prenatal antibody screening test", Korean J Blood Transfus, 16, pp.14~19 (2005)
- Minuk L, "Approach to red blood cell antibody testing during pregnancy : answers to commonly asked questions", Can Fam Physician, 66, pp.491~498 (2020)